Skip to main content
Melissa Cunningham on Muck Rack

Melissa Cunningham

Verified
Melbourne
As seen in: The Age, MSN Australia, Stuff.co.nz, Sydney Morning Herald, Naked City, The Sunday Age, The Canberra Times, Brisbane Times, EIN News, Santa Barbara Independent, WAtoday and
Reporter at The Age. Contact me here: m.cunningham@theage.com.au theage.com.au theage.com.au/by/melissa-cun…

Get in touch with Melissa

Contact Melissa, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Young teens risk mental health after one year of social media use, Australian study shows

|
By Melissa Cunningham Verified
| The Post (Wellington)
Melbourne teenagers Lauren Linton and Kyra Posser have grown up using social media to stay connected with their peers.Sydney Morning Herald Australia Children aged 12 to 13 are the most at risk of mental health issues from heavy use of social media and show a worrying decline in their psychological wellbeing after just one year.
Open in Who Shared View Duplicates (8) Issue with article?

This couple lost $250k when their financial planner gambled it away. They are demanding reform

|
By Melissa Cunningham Verified, Cameron Houston Verified
| EIN News
Save Normal text sizeLarger text sizeVery large text size Weeks before disgraced financial planner and gambling addict Anthony Del Vecchio’s crime spree was exposed, he was celebrating with two of his victims at a wedding. The 32-year-old fraudster told Mildura couple Aimee and Nick Mazza, who had invested $250,000 into what has now been exposed as Del Vecchio’s private Ponzi scheme, their funds would be “maturing very soon”. Want to unlock unlimited news?
Open in Who Shared Issue with article?

Revolutionary new transplant technique breaks down transplant barriers

|
By Melissa Cunningham Verified, Eddie Jim Verified
| Austin Health
In Rob’s case, his elevated antibodies followed a brush with death after cardiac surgery that left him in intensive care for weeks and required several blood transfusions. Imlifidase, an antibody-cleaving enzyme developed by Swedish company Hansa Biopharma, has been described as a game changer by global organ transplant pioneers.
Open in Who Shared Issue with article?
See all 29 licensed articles (7,023 Total)